Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4309-4317

  Kremer, Laurent ^a,b   Riveau, Gilles ^a   Baulard, Alain ^b   Capron, André ^a   Locht, Camille ^b  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; SCHISTOSOMA VACCINE;

ADOLESCENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; FEMALE; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENETIC VECTORS; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; NEUTRALIZATION TESTS; RECOMBINATION, GENETIC; SCHISTOSOMA MANSONI;

EID: 0029885360     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. World Health Organization. 1993. The control of schistosomiasis: second report of the WHO expert committee. WHO Technical Report Series No. 83.
2. Phillips, S. M., and P. Lammie. 1986. Immunopathology of granuloma formation and fibrosis in schistosomiasis. Parasit. Today 2:296.
3. Dunne, D. W., P. Hagan, and F. G. C. Abath. 1995. Prospects for immunological control of schistosomiasis. Lancet 345:1488.
4. Wolowczuk, I., C. Auriault, H. Gras-Masse, C. Vendeville, J.-M. Balloul, A. Tartar, and A. Capron. 1989. Protective immunity in mice vaccinated with the Schistosoma mansoni P28-1 antigen. J. Immunol. 142:1342.
5. Grezel, D., M. Capron, J.-M. Grzych, J. Fontaine, J.-P. Lecocq, and A. Capron. 1993. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Eur. J. Immunol. 23:454.
6. Boulanger, D., G. D. Reid, R. F. Sturrock, I. Wolowczuk, J.-M. Balloul, D. Grezel, R. J. Pierce, M. F. Otieno, S. Guerret, J. A. Grimaud, A. E. Butterworth, and A. Capron. 1991. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 13:473.
7. Xu, C. B., C. Verwaerde, J.-M. Grzych, J. Fontaine, and A. Capron. 1991. A monoclonal antibody blocking the Schistosoma mansoni 28 kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur. J. Immunol. 21:1801.
8. Auriault, C., H. Gras-Masse, R. J. Pierce, A. E. Butterworth, I. Wolowczuk, M. Capron, J. H. Ouma, J.-M. Balloul, J. Khalife, J.-L. Neyrinck, A. Tartar, D. Koech, and A. Capron. 1990. Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione S-transferase and to synthetic peptides. J. Clin. Microbiol. 28:1918.
9. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698.
10. Ladel, C. H., S. Daugelat, and S. H. E. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:3377.
11. Huygen, K., L. Ljungqvist, R. Ten Berg, and J. P. Van Vooren. 1990. Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG. Infect. Immun. 58:2192.
12. Bloom, B. R., S. B. Snapper, T. Kieser, and W. R. Jacobs, Jr. 1990. Development of recombinant BCG vaccines. Semin. Virol. 1:21.
13. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:458.
14. Stover, C. K., V. F. de la Cruz, G. P. Bansal, M. S. Hanson, T. R. Fuerst, W. R. Jacobs, and B. R. Bloom. 1992. Use of recombinant BCG as a vaccine delivery vehicle. In Genetically Engineered Vaccines. J. E. Ciardi, J. R. McGhee, and J. M. Keith, eds. Plenum Press, New York, p. 175.
15. Yasutomi, Y., S. Koenig, S. S. Haun, C. K. Stover, R. K. Jackson, P. Conrad, A. J. Conley, E. A. Emini, T. R. Fuerst, and N. L. Letvin. 1993. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150:3101.
16. Langermann, S., S. R. Palaszynski, J. E. Burlein, S. Koenig, M. S. Hanson, D. E. Briles, and K. Stover. 1994. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180:2277.
17. Grzych, J.-M., D. Grezel, C. B. Xu, J.-L. Neyrinck, M. Capron, J. H. Ouma, A. E. Butterworth, and A. Capron. 1993. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J. Immunol. 150:527.
18. Kremer, L., A. Baulard, J. Estaquier, J. Content, A. Capron, and C. Locht. 1995. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J. Bacteriol. 177:642.
19. Kremer, L., A. Baulard, J. Estaquier, O. Poulain-Godefroy, and C. Locht. 1995. Green fluorescent protein as a new expression marker in mycobacteria. Mol. Microbiol. 17:913.
20. Baulard, A., C. Jourdan, A. Mercenier, and C. Locht. 1992. Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Res. 20:4105.
21. Sambrook, J., F. E. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press.
22. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911.
23. Sauton, B. 1912. Sur la nutrition minérale du bacille tuberculeux. C. R. Hebd. Séances Acad. Sci. 155:1860.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
25. Aldovini, A., and R. A. Young. 1991. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351:479.
26. Xu, C. B., C. Verwaerde, J.-M. Grzych, J. Fontaine, and A. Capron. 1991. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur. J. Immunol. 21:1801.
27. Lagranderie, M., A. Murray, B. Gicquel, C. Leclerc, and M. Gheorghiu. 1993. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 11:1283.
28. Taylor, M. G., and Q. D. Bickle. 1986. Towards a schistosomiasis vaccine: irradiated schistosomes vaccines. Parasitol. Today 2:132.
29. Smythies, L. E., P. S. Coulson, and R. A. Wilson. 1992. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:3654.
30. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion of CD4 lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:1.
31. Murray, A., N. Winter, M. Lagranderie, D. F. Hill, J. Rauzier, J. Timm, C. Leclerc, K. M. Moriarty, M. Gheorghiu, and B. Gicquel. 1992. Expression of Esherichia coli β-galactosidase in Mycobacterium bovis BCG using an expression system from Mycobacterium paratuberculosis which induced humoral and cellular immune responses. Mol. Microbiol. 6:3331.
32. Winter, N., M. Lagranderie, J. Rauzier, J. Timm, C. Leclerc, B. Guy, M. P. Kieny, M. Gheorghiu, and B. Gicquel. 1991. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene 109:47.
33. Winter, N., M. Lagranderie, S. Gangloff, C. Leclerc, M. Gheorghiu, and B. Gicquel. 1995. Recombinant BCG strains expressing the SIVmac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13:471.
34. Connell, N. D., E. Medina-Acosta, W. R. McMaster, B. R. Bloom, and D. G. Russell. 1993. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90:11473.
35. Langermann, S., S. Palaszynski, A. Sadziene, C. K. Stover, and S. Koenig. 1994. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372:552.
36. Khan, C. M. A., B. Villarreal-Ramos, R. J. Pierce, G. Riveau, R. D. de Hormaeche, H. McNeill, T. Ali, N. Fairweather, S. Chatfield, A. Capron, G. Dougan, and C. E. Hormaeche. 1994. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. USA 91:11261.
37. Schein, C. H., and M. H. M. Noteborn. 1988. Formation of soluble recombinant proteins in Escherichia coli is favoured by lower growth temperature. Biotechnology 6:291.
38. Butterworth, A. E. 1992. Vaccines against schistosomiasis: where do we stand? Trans. R. Soc. Trop. Med. Hyg. 86:1.
39. Bout, D., H. Dupas, Y. Carlier, D. Afchain, and A. Capron. 1977. High resistance induced by young live bacillus Calmette-Guérin (BCG) to Schistosoma mansoni infection in mice. Ann. Immunol. 128C:811.